Literature DB >> 14681236

Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.

Huiren Zhao1, M Margarida Bernardo, Pamela Osenkowski, Anjum Sohail, Duanqing Pei, Hideaki Nagase, Masahide Kashiwagi, Paul D Soloway, Yves A DeClerck, Rafael Fridman.   

Abstract

The membrane type (MT)-matrix metalloproteinases (MMPs) constitute a subgroup of membrane-anchored MMPs that are major mediators of pericellular proteolysis and physiological activators of pro-MMP-2. The MT-MMPs also exhibit differential inhibition by members of the tissue inhibitor of metalloproteinase (TIMP) family. Here we investigated the processing, catalytic activity, and TIMP inhibition of MT3-MMP (MMP-16). Inhibitor profile and mutant enzyme studies indicated that MT3-MMP is regulated on the cell surface by autocatalytic processing and ectodomain shedding. Inhibition kinetic studies showed that TIMP-3 is a high affinity inhibitor of MT3-MMP when compared with MT1-MMP (K(i) = 0.008 nm for MT3-MMP versus K(i) = 0.16 nm for MT1-MMP). In contrast, TIMP-2 is a better inhibitor of MT1-MMP. MT3-MMP requires TIMP-2 to accomplish full pro-MMP-2 activation and this process is enhanced in marimastatpretreated cells, consistent with regulation of active enzyme turnover by synthetic MMP inhibitors. TIMP-3 also enhances the activation of pro-MMP-2 by MT3-MMP but not by MT1-MMP. TIMP-4, in contrast, cannot support pro-MMP-2 activation with either enzyme. Affinity chromatography experiments demonstrated that pro-MMP-2 can assemble trimolecular complexes with a catalytic domain of MT3-MMP and TIMP-2 or TIMP-3 suggesting that pro-MMP-2 activation by MT3-MMP involves ternary complex formation on the cell surface. These results demonstrate that TIMP-3 is a major regulator of MT3-MMP activity and further underscores the unique interactions of TIMPs with MT-MMPs in the control of pericellular proteolysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14681236     DOI: 10.1074/jbc.M308708200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  The cytosolic domain of protein-tyrosine kinase 7 (PTK7), generated from sequential cleavage by a disintegrin and metalloprotease 17 (ADAM17) and γ-secretase, enhances cell proliferation and migration in colon cancer cells.

Authors:  Hye-Won Na; Won-Sik Shin; Andreas Ludwig; Seung-Taek Lee
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein.

Authors:  Marcia L Moss; Gary Powell; Miles A Miller; Lori Edwards; Bin Qi; Qing-Xiang Amy Sang; Bart De Strooper; Ina Tesseur; Stefan F Lichtenthaler; Mara Taverna; Julia Li Zhong; Colin Dingwall; Taheera Ferdous; Uwe Schlomann; Pei Zhou; Linda G Griffith; Douglas A Lauffenburger; Robert Petrovich; Jörg W Bartsch
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

3.  Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution.

Authors:  Valeria Arkadash; Gal Yosef; Jason Shirian; Itay Cohen; Yuval Horev; Moran Grossman; Irit Sagi; Evette S Radisky; Julia M Shifman; Niv Papo
Journal:  J Biol Chem       Date:  2017-01-13       Impact factor: 5.157

4.  Active matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers.

Authors:  Mary Jo Murnane; Jinguo Cai; Sania Shuja; David McAneny; John B Willett
Journal:  Hum Pathol       Date:  2011-01-15       Impact factor: 3.466

5.  The stretch responsive microRNA miR-148a-3p is a novel repressor of IKBKB, NF-κB signaling, and inflammatory gene expression in human aortic valve cells.

Authors:  Vishal Patel; Katrina Carrion; Andrew Hollands; Andrew Hinton; Thomas Gallegos; Jeffrey Dyo; Roman Sasik; Emma Leire; Gary Hardiman; Salah A Mohamed; Sanjay Nigam; Charles C King; Victor Nizet; Vishal Nigam
Journal:  FASEB J       Date:  2015-01-28       Impact factor: 5.191

6.  Insights into ectodomain shedding and processing of protein-tyrosine pseudokinase 7 (PTK7).

Authors:  Vladislav S Golubkov; Alex Y Strongin
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

Review 7.  MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer.

Authors:  Anjum Sohail; Qing Sun; Huiren Zhao; M Margarida Bernardo; Jin-Ah Cho; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

8.  Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.

Authors:  Xiaomeng Ma; Ying Jiang; Aimin Wu; Xiaohong Chen; Rongbiao Pi; Mei Liu; Yingying Liu
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

9.  New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.

Authors:  Laetitia Devy; Daniel T Dransfield
Journal:  Biochem Res Int       Date:  2010-10-28

10.  Tumor necrosis factor alpha-dependent aggrecan cleavage and release of glycosaminoglycans in the meniscus is mediated by nitrous oxide-independent aggrecanase activity in vitro.

Authors:  Henning Voigt; Angelika K Lemke; Rolf Mentlein; Michael Schünke; Bodo Kurz
Journal:  Arthritis Res Ther       Date:  2009-09-24       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.